Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Conditions
- Advanced Adult Hepatocellular Carcinoma
- BCLC Stage C Hepatocellular Carcinoma
- Recurrent Adult Hepatocellular Carcinoma
- Stage III Hepatocellular Carcinoma AJCC v7
- Stage IIIA Hepatocellular Carcinoma AJCC v7
- Stage IIIB Hepatocellular Carcinoma AJCC v7
- Stage IIIC Hepatocellular Carcinoma AJCC v7
- Stage IV Hepatocellular Carcinoma AJCC v7
- Stage IVA Hepatocellular Carcinoma AJCC v7
- Stage IVB Hepatocellular Carcinoma AJCC v7
- Unresectable Hepatocellular Carcinoma
Interventions
- OTHER: Laboratory Biomarker Analysis
- OTHER: Quality-of-Life Assessment
- DRUG: Sorafenib
- DRUG: Sorafenib Tosylate
- RADIATION: Yttrium Y 90 Glass Microspheres
Sponsor
M.D. Anderson Cancer Center
Collaborators